IL-17/CXCL5 signaling within the oligovascular niche mediates human and mouse white matter injury

Guanxi Xiao1, Rosie Kumar1, Yutaro Komuro1

  • 1Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

Cell Reports
|December 21, 2022
PubMed

Insights

Diet-induced obesity disrupts brain repair by activating interleukin-17B (IL-17B) signaling, which impairs oligodendrocyte progenitor cells (OPCs). Blocking IL-17B may restore white matter repair and offers a biomarker for cognitive impairment.

Area of Science:

  • Neuroscience
  • Immunology
  • Vascular Biology

Background:

  • Cardiovascular risk factors, including obesity, exacerbate cerebral small vessel disease and white matter injury.
  • Molecular pathways in cerebral endothelial cells are altered by chronic risk factors, hindering white matter repair.

Purpose of the Study:

  • To investigate the molecular mechanisms by which diet-induced obesity (DIO) affects the oligovascular niche in subcortical white matter.
  • To identify signaling pathways involved in impaired brain repair.

Main Methods:

  • Utilized cell-specific translating ribosome affinity purification (RiboTag) in white matter endothelia and oligodendrocyte progenitor cells (OPCs).
  • Investigated the role of interleukin-17B (IL-17B) and its receptor (IL-17Rb) in DIO.
  • Assessed the impact of CXCL5 on OPCs and vascular interactions.

Main Results:

  • DIO triggers a coordinated interleukin-chemokine signaling cascade in the white matter oligovascular niche.
  • IL-17B signaling increases endothelial CXCL5 expression, promoting OPC-vasculature association and migration.
  • Targeted blockade of IL-17B reduced vessel-associated OPCs by decreasing endothelial CXCL5.

Conclusions:

  • Obesity-induced IL-17B signaling disrupts the white matter repair process by affecting OPCs via CXCL5.
  • CXCL5 in blood serves as a diagnostic and prognostic biomarker for vascular cognitive impairment in human cohorts.